Zarządzanie pooperacyjnym dyskomfortem powierzchni oka Raport konferencyjny
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
mar 31, 2025
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
Pobrania
Dane pobrania nie są jeszcze dostepne
##plugins.themes.bootstrap3.article.details##
Jak cytować
1.
Roszkowska AM. Zarządzanie pooperacyjnym dyskomfortem powierzchni oka. Ophthatherapy [Internet]. 31 marzec 2025 [cytowane 6 sierpień 2025];12(1):65-8. Dostępne na: https://www.journalsmededu.pl/index.php/ophthatherapy/article/view/3312
Numer
Dział
Leczenie zachowawcze
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
Bibliografia
1. Devgan U. Optimal vision requires healthy ocular surface in cataract, refractive patients. Ocular Surgery News U.S. Edition. 2009; August 25.
2. Miura M, Inomata T, Nakamura M. Prevalence and Characteristics of Dry Eye Disease After Cataract Surgery: A Systematic Review and Meta Analysis. Ophthalmol Ther. 2022; 11(4): 1309-32.
3. Sajnani R, Raia S, Gibbons A et al. Epidemiology of Persistent Postsurgical Pain Manifesting as Dry Eye Like Symptoms After Cataract Surgery. Cornea. 2018; 37(12): 1535-41.
4. Stapleton F, Alves M, Bunya VY et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017; 15(3): 334-65.
5. Liu Z, Luo L, Zhang Z et al. Tear film changes after phacoemulsification. Zhonghua Yan Ke Za Zhi. 2002; 38(5): 274-7.
6. Oh T, Jung Y, Chang D. Changes in the tear film and ocular surface after cataract surgery. Jpn J Ophthalmol. 2012; 56(2): 113-8.
7. Hirabayashi MT, Barnett BP. Solving STODS-Surgical Temporary Ocular Discomfort Syndrome. Diagnostics (Basel). 2023; 13(5): 837.
8. Iglesias E, Sajnani R, Levitt RC et al. Epidemiology of Persistent Dry Eye Like Symptoms After Cataract Surgery. Cornea. 2018; 37(7): 893-8.
9. Mencucci R, Vignapiano R, Rubino P. et al. Iatrogenic Dry Eye Disease: Dealing with the Conundrum of Post-Cataract Discomfort. A P.I.C.A.S.S.O. Board Narrative Review. Ophthalmol Ther 2021; 10(2): 211-23.
10. Nair S, Kaur M, Sharma N et al. Refractive surgery and dry eye-An update. Indian J Ophthalmol. 2023; 71(4): 1105-14.
11. De Paiva CS, Chen Z, Koch DD et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol. 2006; 141(3): 438-45.
12. Baudouin C, Messmer EM, Aragona P et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016; 100(3): 300-6.
13. Aragona P, Giannaccare G, Mencucci R et al. Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. boardreview. Br J Ophthalmol. 2021; 105(4): 446-53.
14. Betz J, Behrens H, Harkness BM et al. Ocular Pain after Refractive Surgery: Interim Analysis of Frequency and Risk Factors. Ophthalmology. 2023; 130(7): 692-701.
15. Labetoulle M, Benitez-del-Castillo JM, Barabino S et al. Artificial tears: biological role of their ingredients in the management of dry eye disease. Int J Mol Sci. 2022; 23: 2434.
16. Mencucci R, Strazzabosco G, Cristofori V et al. GlicoPro, Novel Standardized and Sterile Snail Mucus Extractfor Multi Modulative Ocular Formulations: New Perspective in Dry Eye Disease Management. Pharmaceutics. 2021; 13(12): 2139.
17. Dufour E, Villard-Saussine S, Mellon V. Opiorphin secretion pattern in healthy volunteers: gender difference and organ specificity. Biochem Anal Biochem. 2013; 2: 136.
18. Ozdogan S, Sonmez C, Yolcu D et al. Tear Opiorphin Levels in Ocular Pain Caused by Corneal Foreign Body. Cornea. 2020; 39(11): 1377-80.
19. Giannaccare G, Vaccaro S, Borselli M et al. A Novel Ophthalmic Solution Containing Glicopro® Complex for the Treatment of Patients with Dry Eye Disease: Results from a Pilot Study. J Clin Med. 2024; 13(5):1447.
20. Ballesteros-Sánchez A, Sánchez-González JM, Tedesco GR et al. Evaluating GlicoPro Tear Substitute Derived from Helix aspersa Snail Mucus in Alleviating Severe Dry Eye Disease: A First-in-Human Study on Corneal Esthesiometry Recovery and Ocular Pain Relief. J Clin Med. 2024; 13(6): 1618.
2. Miura M, Inomata T, Nakamura M. Prevalence and Characteristics of Dry Eye Disease After Cataract Surgery: A Systematic Review and Meta Analysis. Ophthalmol Ther. 2022; 11(4): 1309-32.
3. Sajnani R, Raia S, Gibbons A et al. Epidemiology of Persistent Postsurgical Pain Manifesting as Dry Eye Like Symptoms After Cataract Surgery. Cornea. 2018; 37(12): 1535-41.
4. Stapleton F, Alves M, Bunya VY et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017; 15(3): 334-65.
5. Liu Z, Luo L, Zhang Z et al. Tear film changes after phacoemulsification. Zhonghua Yan Ke Za Zhi. 2002; 38(5): 274-7.
6. Oh T, Jung Y, Chang D. Changes in the tear film and ocular surface after cataract surgery. Jpn J Ophthalmol. 2012; 56(2): 113-8.
7. Hirabayashi MT, Barnett BP. Solving STODS-Surgical Temporary Ocular Discomfort Syndrome. Diagnostics (Basel). 2023; 13(5): 837.
8. Iglesias E, Sajnani R, Levitt RC et al. Epidemiology of Persistent Dry Eye Like Symptoms After Cataract Surgery. Cornea. 2018; 37(7): 893-8.
9. Mencucci R, Vignapiano R, Rubino P. et al. Iatrogenic Dry Eye Disease: Dealing with the Conundrum of Post-Cataract Discomfort. A P.I.C.A.S.S.O. Board Narrative Review. Ophthalmol Ther 2021; 10(2): 211-23.
10. Nair S, Kaur M, Sharma N et al. Refractive surgery and dry eye-An update. Indian J Ophthalmol. 2023; 71(4): 1105-14.
11. De Paiva CS, Chen Z, Koch DD et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol. 2006; 141(3): 438-45.
12. Baudouin C, Messmer EM, Aragona P et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016; 100(3): 300-6.
13. Aragona P, Giannaccare G, Mencucci R et al. Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. boardreview. Br J Ophthalmol. 2021; 105(4): 446-53.
14. Betz J, Behrens H, Harkness BM et al. Ocular Pain after Refractive Surgery: Interim Analysis of Frequency and Risk Factors. Ophthalmology. 2023; 130(7): 692-701.
15. Labetoulle M, Benitez-del-Castillo JM, Barabino S et al. Artificial tears: biological role of their ingredients in the management of dry eye disease. Int J Mol Sci. 2022; 23: 2434.
16. Mencucci R, Strazzabosco G, Cristofori V et al. GlicoPro, Novel Standardized and Sterile Snail Mucus Extractfor Multi Modulative Ocular Formulations: New Perspective in Dry Eye Disease Management. Pharmaceutics. 2021; 13(12): 2139.
17. Dufour E, Villard-Saussine S, Mellon V. Opiorphin secretion pattern in healthy volunteers: gender difference and organ specificity. Biochem Anal Biochem. 2013; 2: 136.
18. Ozdogan S, Sonmez C, Yolcu D et al. Tear Opiorphin Levels in Ocular Pain Caused by Corneal Foreign Body. Cornea. 2020; 39(11): 1377-80.
19. Giannaccare G, Vaccaro S, Borselli M et al. A Novel Ophthalmic Solution Containing Glicopro® Complex for the Treatment of Patients with Dry Eye Disease: Results from a Pilot Study. J Clin Med. 2024; 13(5):1447.
20. Ballesteros-Sánchez A, Sánchez-González JM, Tedesco GR et al. Evaluating GlicoPro Tear Substitute Derived from Helix aspersa Snail Mucus in Alleviating Severe Dry Eye Disease: A First-in-Human Study on Corneal Esthesiometry Recovery and Ocular Pain Relief. J Clin Med. 2024; 13(6): 1618.